March 14, 2017 / 11:53 AM / in 6 months

BUZZ-Valeant Pharmaceuticals shares near 8-year low on Ackman's exit

** Valeant Pharmaceuticals U.S.-listed shares plunging about 12 pct to lowest levels since May 2009 premarket as Pershing Square sells its entire stake

** VRX most active across all U.S. exchanges premarket with over 700 mln shares exchanging hands

** Jefferies bought 27.2 mln shares from Pershing at $11.00 and marketing the unregistered block in range of $11.10-$11.40, a 5.9-8.3 pct discount to stock’s last sale on Mon

** Block represents about 8 pct of Valeant’s total shares outstanding and more than a full day’s worth of trading volume based on stock’s 30-day avg

** Billionaire investor hedge fund manager William Ackman taking a loss of more than $3 bln after trying to rescue the struggling Canadian drugmaker for some 18 months

** The exit “will enable us to dedicate more time to our other portfolio companies and new investment opportunities” - Ackman

** Valeant’s stock has fallen 83 pct over past one year through Mon’s close

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below